Impact Of Gene Mutations On Response To Lenalidomide And Os In Lower-Risk Non-Del(5Q) Mds Patients Ineligible/Refractory To Erythropoiesis-Stimulating Agents (Esas)
AuthID
P-00N-CER
P-00N-CER
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service